BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fhu CW, Ali A. Dysregulation of the Ubiquitin Proteasome System in Human Malignancies: A Window for Therapeutic Intervention. Cancers (Basel) 2021;13:1513. [PMID: 33805973 DOI: 10.3390/cancers13071513] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu N, Cui Y, Shi H, Guo G, Sun F, Jian T, Rao H. UBE2T/STAT3 Signaling Promotes the Proliferation and Tumorigenesis in Retinoblastoma. Invest Ophthalmol Vis Sci 2022;63:20. [PMID: 35980647 DOI: 10.1167/iovs.63.9.20] [Reference Citation Analysis]
2 Ke HL, Lee YC, Li WM, Wang CS, Hsu WC, Lin HH, Lee YA, Jhan JH, Li CC, Yeh HC, Wu WJ, Huang AM. High Ubiquitin-Specific Protease 2a Expression Level Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma. Appl Immunohistochem Mol Morphol 2022;30:304-10. [PMID: 35384881 DOI: 10.1097/PAI.0000000000001014] [Reference Citation Analysis]
3 Cao Y, Tu Y, Fu L, Yu Q, Gao L, Zhang M, Zeng L, Zhang C, Shao J, Zhu H, Zhou Y, Li J, Zhang J. Metabolism guided optimization of peptidomimetics as non-covalent proteasome inhibitors for cancer treatment. Eur J Med Chem 2022;233:114211. [PMID: 35218994 DOI: 10.1016/j.ejmech.2022.114211] [Reference Citation Analysis]
4 Cable J, Weber‐ban E, Clausen T, Walters KJ, Sharon M, Finley DJ, Gu Y, Hanna J, Feng Y, Martens S, Simonsen A, Hansen M, Zhang H, Goodwin JM, Reggio A, Chang C, Ge L, Schulman BA, Deshaies RJ, Dikic I, Harper JW, Wertz IE, Thomä NH, Słabicki M, Frydman J, Jakob U, David DC, Bennett EJ, Bertozzi CR, Sardana R, Eapen VV, Carra S. Targeted protein degradation: from small molecules to complex organelles—a Keystone Symposia report. Annals NY Academy of Science. [DOI: 10.1111/nyas.14745] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Staszczak M. Fungal Secondary Metabolites as Inhibitors of the Ubiquitin-Proteasome System. Int J Mol Sci 2021;22:13309. [PMID: 34948102 DOI: 10.3390/ijms222413309] [Reference Citation Analysis]
6 Li KX, Sun X, Li BY, Yokota H. Conversion of Osteoclasts into Bone-Protective, Tumor-Suppressing Cells. Cancers (Basel) 2021;13:5593. [PMID: 34830748 DOI: 10.3390/cancers13225593] [Reference Citation Analysis]
7 Abdalbari FH, Telleria CM. The gold complex auranofin: new perspectives for cancer therapy. Discov Onc 2021;12. [DOI: 10.1007/s12672-021-00439-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
8 Pan K, Fu J, Xu W. Role of Ubiquitin-Specific Peptidase 47 in Cancers and Other Diseases. Front Cell Dev Biol 2021;9:726632. [PMID: 34604226 DOI: 10.3389/fcell.2021.726632] [Reference Citation Analysis]
9 Wang L, Sun X, He J, Liu Z. Functions and Molecular Mechanisms of Deltex Family Ubiquitin E3 Ligases in Development and Disease. Front Cell Dev Biol 2021;9:706997. [PMID: 34513839 DOI: 10.3389/fcell.2021.706997] [Reference Citation Analysis]
10 Sankiewicz A, Guszcz T, Gorodkiewicz E. Application of SPRi Biosensors for Determination of 20S Proteasome and UCH-L1 Levels in the Serum and Urine of Transitional Bladder Cancer Patients. Applied Sciences 2021;11:7835. [DOI: 10.3390/app11177835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Liu J, Knani I, Gross-Cohen M, Hu J, Wang S, Tang L, Ilan N, Yang S, Vlodavsky I. Role of heparanase 2 (Hpa2) in gastric cancer. Neoplasia 2021;23:966-78. [PMID: 34343822 DOI: 10.1016/j.neo.2021.07.010] [Reference Citation Analysis]